Meanwhile, UBA52, SRSF2, RAP1A, CTNNB1, and CDK6 were associated with unfavorable prognosis of GBM and LGG patients (Figures 3(c), 3(e), 3(f), 3(k), and 3(l)). This evidence concerns the gene SRSF2 and glioblastoma.